XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Summary of Significant Accounting Policies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Summary of Significant Accounting Policies |
Schedule of change in the research and development incentive receivable | The following table shows the change in the research and development incentive receivable from January 1, 2020 to December 31, 2021: ​
​ | ​ | ​ | ​
Balance at January 1, 2020 |  | $ | 185
Australian research and development incentive income, net | ​ |  | 231
Cash received for 2019 eligible expenses | ​ |  | (331)
Foreign currency translation | ​ | ​ | (12)
Balance at December 31, 2020 | ​ |  | 73
Australian research and development incentive income, net | ​ | ​ | 1,226
Cash received for 2020 eligible expenses | ​ |  | (111)
Foreign currency translation | ​ |  | 1
Balance at December 31, 2021 | ​ | $ | 1,189
Summary of assets and liabilities carried at fair value in accordance with the hierarchy | A summary of the assets and liabilities carried at fair value in accordance with the hierarchy defined above is as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Total |  | Level 1 |  | Level 2 |  | Level 3
December 31, 2021 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash equivalents | ​ | $ | 112,726 | ​ | $ | 112,726 | ​ | $ | — | ​ | $ | —
Total assets | ​ | $ | 112,726 | ​ | $ | 112,726 | ​ | $ | — | ​ | $ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
December 31, 2020 | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Assets: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Cash equivalents | ​ | $ | 51,116 | ​ | $ | 51,116 | ​ | $ | — | ​ | $ | —
Total assets | ​ | $ | 51,116 | ​ | $ | 51,116 | ​ | $ | — | ​ | $ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Restricted stock liability | ​ | $ | 204 | ​ | $ | 204 | ​ | $ | — | ​ | $ | —
Total liabilities | ​ | $ | 204 | ​ | $ | 204 | ​ | $ | — | ​ | $ | —

X
- Definition Tabular disclosure of the change in research and development incentive receivable. + References No definition available. + Details
Name: | lptx_ScheduleOfChangeInResearchAndDevelopmentIncentiveReceivableTableTextBlock
Namespace Prefix: | lptx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration